Marginal zone cell lymphoma - An update on recent advances

Histopathology

Volumn 40, Issue 2, 2002, Pages 117-126

  Maes, B ^a,b   De Wolf Peeters, C ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Extranodal marginal zone B cell lymphoma; MALT; MALT type lymphoma; Marginal zone B cells; Monocytoid B cells; Mucosa associated lymphoid tissue; Nodal marginal zone B cell lymphoma; Splenic marginal zone B cell lymphoma

Indexed keywords

B CELL LYMPHOMA; CELL COMPOSITION; CELL FUNCTION; CELL HETEROGENEITY; CELL SIZE; CELL STRUCTURE; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; CLINICAL FEATURE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; IMMUNOPHENOTYPING; INFLAMMATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; LYMPHOMA CELL; MARGINAL ZONE B CELL LYMPHOMA; MESENTERY LYMPH NODE; PATHOGENESIS; PEYER PATCH; PRIORITY JOURNAL; REVIEW; SPLEEN LYMPHOCYTE; TRISOMY; TUMOR GROWTH; TUMOR LOCALIZATION;

B-LYMPHOCYTES; HUMANS; LYMPH NODES; LYMPHOMA, B-CELL; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE;

EID: 0036162085     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2002.01360.x     Document Type: Review

References (116)

1. Anatomy and histophysiology of lymphoid tissue
2. Marginal zones: The major B cell compartment of rat spleens
3. Normal histology of the human spleen
4. Gut associated lymphoid tissue: A morphological and immunocytochemical study of the human appendix
5. Human tonsil intraepithelial B cells: A marginal zone-related subpopulation
6. Immature sinus histiocytosis. Light- and electron-microscopic features, immunologic phenotype, and relationship with marginal zone lymphocytes
7. The marginal zone in the human reactive lymph node
8. Diagnose und aetiologie der piringerschen lymphadenitis
9. 'Monocytoid' cells in reactive follicular hyperplasia with and without multifocal histiocytic reactions: An immunohistochemical study of 21 cases including suspected cases of toxoplasmic lymphadenitis
10. Immature sinus histiocytes. Their identification as a novel B-cell population
11. Monocytoid B cells are distinct from splenic marginal zone cells and commonly derive from unmutated naive B cells and less frequently from postgerminal center B cells by polyclonal transformation
12. Human marginal-zone B cells
13. Phenotypic expression of B lymphocytes. III. Marginal zone B cells in the spleen are characterized by the expression of Tac and alkaline phosphatase
14. Human marginal zone B cells are not an activated B cell subset: Strong expression of CD21 as a putative mediator for rapid B cell activation
15. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response
16. Splenic dependence of the antibody response to thymus-independent (TI-2) antigens
17. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses
18. Human immune response to pneumococcal polysaccharides: Complement-mediated localization preferentially on CD21-positive splenic marginal zone B cells and follicular dendritic cells
19. Immaturity of the human splenic marginal zone in infancy. Possible contribution to the deficient infant immune response
20. Impaired human antibody response to the thymus-independent antigen, DNP-Ficoll, after splenectomy. Implications for postsplenectomy infections
21. Memory B cells in T cell-dependent antibody responses colonize the splenic marginal zones
22. high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells
23. Analysis of mutations in immunoglobulin heavy chain variable region genes of microdissected marginal zone (MGZ) B cells suggests that the MGZ of human spleen is a reservoir of memory B cells
24. H genes from microdissected human Peyer's patch marginal zone B cells
25. Marginal-zone B cells in the human lymph node and spleen show somatic hypermutations and display clonal expansion
26. Intraclonal generation of antibody mutants in germinal centers
27. Heterogeneity of tonsillar subepithelial B lymphocytes, the splenic marginal zone equivalents
28. Signaling through focal adhesion kinase
29. B cells on the front line
30. Blys: Member of the tumor necrosis factor family and B lymphocyte stimulator
31. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations
32. Synthesis and release of B-lymphocyte stimulator from myeloid cells
33. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
34. Nuclear factor kappa B is required for the development of marginal zone B lymphocytes
35. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
36. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma
37. Monocytoid B-cell lymphoma: A novel B-cell neoplasm
38. Monocytoid B-cell lymphoma: Clinicopathologic study of 21 cases of a unique type of low-grade lymphoma
39. Report of an unusual lymphoma arising from parafollicular B-lymphocytes or so-called 'monocytoid' lymphocytes
40. The histopathology of splenic lymphoma with villous lymphocytes
41. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the clinical advisory committee meeting, Airlie House, Virginia, November, 1997
42. Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue
43. Malignant lymphoma of the gastrointestinal tract
44. Splenic marginal zone lymphoma
45. Primary nodal marginal zone lymphomas of splenic and MALT type
46. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori
47. Gastrointestinal lymphomas: An overview with emphasis on new findings and diagnostic problems
48. B-cell monoclonality precedes the development of gastric MALT lymphoma in Helicobacter pylori-associated chronic gastritis
49. Relationship between high-grade lymphoma and low-grade B-cell mucosa-associated lymphoid tissue lymphoma (MALToma) of the stomach
50. Histological grading in gastric lymphoma: Pretreatment criteria and clinical relevance
51. Controversies in MALT lymphoma classification, low and high grade
52. Monocytoid B-cell lymphoma: A tumour related to the marginal zone
53. Monocytoid B-cell lymphoma: Morphological variants and relationship to low-grade B-cell lymphoma of mucosa-associated lymphoid tissue
54. The morphological spectrum of monocytoid B-cell lymphoma and its relationship to lymphomas of mucosa-associated lymphoid tissue
55. Monocytoid B cells: A comparative clinical pathological study of their distribution in different types of low-grade lymphomas
56. Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features
57. Marginal zone B-cell lymphomas including mucosa-associated lymphoid tissue type lymphoma (MALT), monocytoid B-cell lymphoma and splenic marginal zone cell lymphoma and their relation to the reactive marginal zone
58. Splenic marginal zone lymphoma: A distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases
59. A genotypic study of low grade B-cell lymphomas, including lymphomas of mucosa associated lymphoid tissue (MALT)
60. Cytogenetic and molecular studies of t(14;18) and t(14;19) in nodal and extranodal B-cell lymphoma
61. Cytogenetic study of B-cell lymphoma of mucosa-associated lymphoid tissue
62. t(11;18)(q21;q21) is the most common translocation in MALT lymphomas
63. The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT) type
64. Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lymphoid tissue
65. Trisomy 3 in marginal zone B-cell lymphoma: A study based on cytogenetic analysis and fluorescence in situ hybridization
66. Numerical cytogenetic abnormalities of chromosomes 3, 7, and 12 in marginal zone B-cell lymphomas
67. Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization
68. BCL6 gene rearrangements also occur in marginal zone B-cell lymphoma
69. t(11;18) (q21;q21.1): A recurring translocation in lymphomas of mucosa-associated lymphoid tissue (MALT)?
70. The product of the t(11;18), an API2-MLT fusion, marks nearly half of the gastro-intestinal MALT type lymphomas without large cell proliferation
71. The product of the t(11;18), an API2-MLT fusion, is an almost exclusive finding in marginal zone cell lymphoma of extranodal MALT-type
72. Molecular cytogenetic delineation of the breakpoint at 18q21.1 in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue
73. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with MALT lymphomas
74. Bcl10 and MALT1, independent targets of chromosomal translocation in MALT lymphoma, cooperate in a novel NF-kappaB signaling pathway
75. The transcription factor NF-kappaB: Control of oncogenesis and cancer therapy resistance
76. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types
77. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32)
78. Lack of BCL10 mutations in germ cell tumors and B cell lymphomas
79. Absence of BCL10 mutations in human malignant mesothelioma
80. Mutations in Bcl10 are very rare in colorectal cancer
81. Lack of Bcl10 mutations in testicular germ cell tumours and derived cell lines
82. Screening for mutations of Bcl10 in leukaemia
83. BCL10 gene mutations rarely occur in lymphoid malignancies
84. BCL10 mutation does not represent an important pathogenic mechanism in gastric malt-type lymphoma and the presence of the API2-MLT fusion is associated with aberrant nuclear BCL10 expression
85. Somatic Fas mutations in non-Hodgkin's lymphoma: Association with extranodal disease and autoimmunity
86. The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma
87. Molecular genetics of gastrointestinal non-Hodgkin's lymphomas: Unusual prevalence and pattern of c-myc rearrangements in aggressive lymphomas
88. Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas
89. Frequent involvement of chromosomes 1, 3, 7 and 8 in splenic marginal zone B-cell lymphoma
90. 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma
91. Novel genomic imbalances in B-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogenetics
92. Somatic hypermutation in low-grade mucosa-associated lymphoid tissue-type B-cell lymphoma
93. Splenic lymphoma with villous lymphocytes involves B cells with extensively mutated Ig heavy chain variable region genes
94. Intestinal dissemination of gastric mucosa-associated lymphoid tissue lymphoma
95. Ongoing mutation in MALT lymphoma immunoglobulin gene suggests that antigen stimulation plays a role in the clonal expansion
96. Molecular Ig gene analysis reveals that monocytoid B cell lymphoma is a malignancy of mature B cells carrying somatically mutated V region genes and suggests that rearrangement of the kappa-deleting element (resulting in deletion of the Ig kappa enhancers) abolishes somatic hypermutation in the human
97. Ongoing Ig gene hypermutation in salivary gland mucosa-associated lymphoid tissue-type lymphomas
98. Mutation analysis of the rearranged immunoglobulin heavy chain genes of marginal zone cell lymphomas indicates an origin from different marginal zone B lymphocyte subsets
99. Low grade gastric B-cell MALT lymphoma progressing into high grade lymphoma. Clonal identity of the two stages of the tumour, unusual bone involvement and leukemic dissemination
100. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma
101. High incidence of primary gastric lymphoma in northeastern Italy
102. Helicobacter pylori infection and gastric lymphoma
103. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori
104. Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue
105. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection: MALT Lymphoma Study Group
106. Primary B cell lymphoma of salivary glands and its relationship to myoepithelial sialadenitis
107. Gastric lymphoma and Helicobacter pylori
108. Mucosa-associated lymphoid tissue lymphomas
109. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma
110. The Non-Hodgkin's Lymphoma Classification Project A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma
111. Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types
112. Splenic marginal zone lymphoma. A distinct B-cell neoplasm
113. Non-MALT marginal zone B-cell lymphomas: A description of clinical presentation and outcome in 124 patients
114. Splenic marginal zone cell lymphoma
115. 'Small' B-cell non-Hodgkin's lymphomas presenting with splenomegaly are either mantle cell lymphoma or marginal zone cell lym-phoma. A study based on histology, immunocytochemistry and cytogenetic analysis